View in EDS

Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.

Saved in:

Bibliographic Details
Title:	Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.
Authors:	Burke KN; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America. Electronic address: kburke53@alumni.jh.edu., Krawczyk N; New York University Grossman School of Medicine, 550 1(st) Ave, New York, NY 10016, United States of America., Li Y; New York University School of Global Public Health, 708 Broadway, New York, NY 10003, United States of America., Byrne L; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America., Desai IK; George Washington University Milken Institute School of Public Health, 950 New Hampshire Ave NW #2, Washington, DC 20037, United States of America., Bandara S; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America., Feder KA; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America.
Source:	Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Jul; Vol. 162, pp. 209351. Date of Electronic Publication: 2024 Mar 17.
Publication Type:	Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918541186406676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-8759 (Electronic) Linking ISSN: 29498759 NLM ISO Abbreviation: J Subst Use Addict Treat Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2949-8759
DOI:	10.1016/j.josat.2024.209351